BioNtech in bid to increase vaccine production by 750 million doses a year

Covid-19 vaccine co-manufacturer buys new manufacturing plant from Novartis in Germany to ramp up production

Daniel Murray

Political Correspondent @danieltmurray
20th December, 2020
BioNtech in bid to increase vaccine production by 750 million doses a year
Sean Marrett of BioNtech. BioNtech hopes to increase the production of Covid-19 vaccines by an additional 750 million doses a year in Europe.

BioNtech hopes to increase the production of Covid-19 vaccines by an additional 750 million doses a year in Europe, the company’s chief commercial officer has told the Business Post.

Sean Marrett of BioNtech, who alongside Pfizer have brought the first Covid-19 vaccine to market, said the company had just bought a new manufacturing plant from Novartis in Germany, and it could produce an additional 750 million doses of the vaccine a year, should it...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Related Stories

Enterprise Ireland chief: global supply chain backlog ‘to continue for another year’

Premier Inn owner files €1.75m loss due to pandemic

Investment funds buy €260m worth of Kingspan shares